
Keywords: AGE; advanced glycation end products; BM-EPCs; bone marrow-derived endothelial progenitor cells; CAD; coronary artery disease; CV; cardiovascular; DM; diabetes mellitus; EPCs; endothelial progenitor cells; G-CSF; granulocyte colony-stimulating factor; HIF